Organism name | Solanum nigrum |
---|---|
Genus | Solanum |
Family | Solanaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Solanum nigrum |
---|---|
Linked NCBI taxonomy ID | 4112 |
Linked level | species |
Family in NCBI taxonomy | Solanaceae |
---|---|
ID | 4070 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00005400
![]() |
Quercetin 3-rhamnosyl-(1->2)-galactoside
|
CHEMBL499824
|
C064703
|
No. 1 | No. 15 |
![]() |
||
C00005399
![]() |
Quercetin 3-glucosyl-(1->6)-galactoside
|
CHEMBL1097317
|
No. 1 | No. 15 |
![]() |
|||
C00005443
![]() |
Quercetin 3-(6'''-rhamnosylgentiobioside)
/ Quercetin 3-rhamnosyl-(1->2)[glucosyl-(1->6)-galactoside] / 3-[(O-6-Deoxy-alpha-L-mannopyranosyl-(1->2)-O-[beta-D-glucopyranosyl-(1->6)]-beta-D-galactopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one |
No. 5 | No. 15 |
![]() |
||||
C00006873
![]() |
Peonanin
/ Peonidin 3-O-[6-O-(4-O-(E)-p-coumaroyl-O-alpha-rhamnopyranosyl)-beta-glucopyranoside]-5-O-beta-glucopyranoside |
No. 7 | No. 15 |
![]() |
||||
C00006913
![]() |
Negretein
|
No. 7 | No. 15 |
![]() |
||||
C00006900
![]() |
Petanin
/ Petunidin 3-O-[6-O-(4-O-(E)-p-coumaroyl-O-alpha-rhamnopyranosyl)-beta-glucopyranoside]-5-O-beta-glucopyranoside |
No. 7 | No. 15 |
![]() |
||||
C00002242
![]() |
alpha-Chaconine
|
C011860
|
No. 17 | No. 11 |
![]() |
|||
C00002262
![]() |
alpha-Solanine
|
CHEMBL1212997
CHEMBL1392894 CHEMBL1975187 CHEMBL2357167 |
D012992
|
13 / 10 / 12 | No. 17 | No. 11 |
![]() |
|
C00041869
![]() |
Solanigroside D
/ (-)-Solanigroside D |
CHEMBL506199
|
No. 21 | No. 11 |
![]() |
|||
C00041873
![]() |
Solanigroside H
/ (-)-Solanigroside H |
CHEMBL449197
|
No. 21 | No. 11 |
![]() |
|||
C00041868
![]() |
Solanigroside C
/ (-)-Solanigroside C |
CHEMBL509104
|
No. 21 | No. 11 |
![]() |
|||
C00041872
![]() |
Solanigroside G
/ (-)-Solanigroside G |
CHEMBL448027
|
No. 21 | No. 11 |
![]() |
|||
C00041871
![]() |
Solanigroside F
/ (-)-Solanigroside F |
CHEMBL526905
|
No. 21 | No. 11 |
![]() |
|||
C00041870
![]() |
Solanigroside E
/ (-)-Solanigroside E |
CHEMBL501125
|
No. 21 | No. 11 |
![]() |
|||
C00002264
![]() |
Solasodine
|
CHEMBL372484
CHEMBL518252 CHEMBL514596 CHEMBL1485302 CHEMBL1515688 CHEMBL1741560 CHEMBL1964743 |
C012037
|
12 / 14 / 46 | No. 171 | No. 11 |
![]() |
|
C00002261
![]() |
Solanidine
|
CHEMBL363703
CHEMBL1534747 CHEMBL1980466 |
C013255
|
5 / 5 / 8 | No. 265 | No. 11 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
O00255 | Menin | Unclassified protein | C00002261 C00002262 C00002264 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002261 C00002262 C00002264 | 1 / 2 |
Q15125 | 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | Enzyme | C00002261 C00002264 | 1 / 1 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00002261 C00002264 | 1 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002262 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00002262 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002264 | 0 / 1 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00002264 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00002262 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00002262 | 2 / 0 |
O75496 | Geminin | Unclassified protein | C00002262 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002262 | 4 / 1 |
Q99700 | Ataxin-2 | Unclassified protein | C00002262 | 1 / 1 |
Q99816 | Tumor susceptibility gene 101 protein | Unclassified protein | C00002262 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00002264 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002264 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002262 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002264 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002264 | 0 / 1 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00002261 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002262 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002264 | 7 / 37 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002264 | 1 / 0 |
P01215 | Glycoprotein hormones alpha chain | Unclassified protein | C00002262 | 0 / 3 |
OMIM | preferred title | UniProt |
---|---|---|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#302960 | Chondrodysplasia punctata 2, x-linked dominant; cdpx2 |
Q15125
|
#114500 | Colorectal cancer; crc |
P84022
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#133239 | Esophageal cancer |
P04637
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#211980 | Lung cancer |
P04637
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00081 | Hashimoto's thyroiditis |
P01215
(marker)
|
H00082 | Graves' disease |
P01215
(marker)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P01215
(marker)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
|
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H01194 | X-linked chondrodysplasia punctata |
Q15125
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|